News | October 06, 2008

TCT 2008 Begins This Weekend in Washington, D.C.

October 7, 2008 - Now in its 20th year the 2008 Transcatheter Cardiovascular Therapeutics (TCT) symposium, sponsored by the Cardiovascular Research Foundation, will take place from Sunday, Oct. 12 through Friday, Oct. 17 at the Washington Convention Center in Washington, D.C.

TCT is said to be the world’s premier conference in interventional cardiology, endovascular medicine, and structural heart disease, where the latest trends, research findings, and techniques are disseminated to practicing physicians from around the world. The symposium will feature live procedures originating from more than 25 leading U.S. and international medical centers featuring world-renowned operators performing complex interventions. Cases will be presented with an interactive and thematic approach in three distinct tracks for coronary, endovascular, and structural heart disease.

Diagnostic and Invasive Cardiology magazine has created the TCT FastPass Web site to guide clinicians through the products being highlighted by manufacturers at the show, and to update them with the latest technology news coming out of the event. Visit new.reillycomm.com/tct/.

For more information: www.tctconference.com


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now